1. Home
  2. CRBU vs PRE Comparison

CRBU vs PRE Comparison

Compare CRBU & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • PRE
  • Stock Information
  • Founded
  • CRBU 2011
  • PRE 2014
  • Country
  • CRBU United States
  • PRE Hong Kong
  • Employees
  • CRBU N/A
  • PRE N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • PRE Biotechnology: Laboratory Analytical Instruments
  • Sector
  • CRBU Health Care
  • PRE Industrials
  • Exchange
  • CRBU Nasdaq
  • PRE Nasdaq
  • Market Cap
  • CRBU 93.0M
  • PRE 105.4M
  • IPO Year
  • CRBU 2021
  • PRE N/A
  • Fundamental
  • Price
  • CRBU $1.02
  • PRE $9.35
  • Analyst Decision
  • CRBU Strong Buy
  • PRE Buy
  • Analyst Count
  • CRBU 4
  • PRE 1
  • Target Price
  • CRBU $8.50
  • PRE $9.00
  • AVG Volume (30 Days)
  • CRBU 943.1K
  • PRE 37.0K
  • Earning Date
  • CRBU 05-08-2025
  • PRE 06-17-2025
  • Dividend Yield
  • CRBU N/A
  • PRE N/A
  • EPS Growth
  • CRBU N/A
  • PRE N/A
  • EPS
  • CRBU N/A
  • PRE N/A
  • Revenue
  • CRBU $9,918,000.00
  • PRE $30,621,000.00
  • Revenue This Year
  • CRBU N/A
  • PRE $148.70
  • Revenue Next Year
  • CRBU $161.81
  • PRE $82.89
  • P/E Ratio
  • CRBU N/A
  • PRE N/A
  • Revenue Growth
  • CRBU N/A
  • PRE 40.83
  • 52 Week Low
  • CRBU $0.66
  • PRE $3.10
  • 52 Week High
  • CRBU $3.00
  • PRE $11.99
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 57.50
  • PRE 69.16
  • Support Level
  • CRBU $0.98
  • PRE $9.14
  • Resistance Level
  • CRBU $1.21
  • PRE $11.99
  • Average True Range (ATR)
  • CRBU 0.10
  • PRE 0.84
  • MACD
  • CRBU 0.02
  • PRE 0.19
  • Stochastic Oscillator
  • CRBU 68.23
  • PRE 61.68

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About PRE Prenetics Global Limited

Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.

Share on Social Networks: